Detalhe da pesquisa
1.
Toxicity and Local Tolerance of a Novel Spike Protein RBD Vaccine Against SARS-CoV-2, Produced Using the C1 Thermothelomyces Heterothallica Protein Expression Platform.
Toxicol Pathol
; 50(3): 294-307, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35514116
2.
In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI-MS spectrum.
Anal Bioanal Chem
; 413(30): 7559-7585, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34739558
3.
Zoonoses Anticipation and Preparedness Initiative, stakeholders conference, February 4 & 5, 2021.
Biologicals
; 74: 10-15, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34736782
4.
Filamentous fungus-produced human monoclonal antibody provides protection against SARS-CoV-2 in hamster and non-human primate models.
Nat Commun
; 15(1): 2319, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485931
5.
Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system Thermothelomyces heterothallica C1.
Front Immunol
; 14: 1204834, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37359531
6.
The Highly Productive Thermothelomyces heterothallica C1 Expression System as a Host for Rapid Development of Influenza Vaccines.
Vaccines (Basel)
; 10(2)2022 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35214607
7.
A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice.
Vaccine
; 40(8): 1162-1169, 2022 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078661
8.
Thermophilic Filamentous Fungus C1-Cell-Cloned SARS-CoV-2-Spike-RBD-Subunit-Vaccine Adjuvanted with Aldydrogel®85 Protects K18-hACE2 Mice against Lethal Virus Challenge.
Vaccines (Basel)
; 10(12)2022 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36560529
9.
Development of a Modular Vaccine Platform for Multimeric Antigen Display Using an Orthobunyavirus Model.
Vaccines (Basel)
; 9(6)2021 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34203630